Search This Blog

Thursday, June 27, 2019

Valeritas files U.S. application for use of regular insulin with V-Go device

Valeritas Holdings (VLRX -2.4%) has filed a supplemental marketing application [called a Special 510(k)] with the FDA seeking clearance to use regular human insulin with its wearable V-Go device. The company says the expanded use, if approved, will save patients money.
V-Go is currently cleared for use with a U100 fast-acting insulin, like rapid-acting insulin analogs, which is more expensive.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.